Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03474588 · ClinicalTrials.gov registry record · NA
CBT4CBT With Spanish Alcohol Users
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT03474588: Completed NA study, sponsored by Yale University.
NCT03474588 is a NA study that has completed, run by Yale University. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03474588, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
Specific aims are as follows: * To adapt our existing CBT4CBT program for use with Spanish-speaking alcohol users in a web-based platform * To conduct an 8-week randomized trial evaluating the feasibility and efficacy of adding CBT4CBT-Spanish to treatment as usual in a community based treatment program in a population of 90 Spanish-speaking individuals who meet current criteria for alcohol use disorder * To evaluate the long-term durability and/or delayed emergence of treatment effects through a six month follow-up after termination of the study treatments. Given previous evidence regarding the durability of standard clinician-delivered CBT and computer-assisted CBT4CBT, we hypothesize that CBT4CBTSpanish will be significantly more effective than standard treatment alone through the follow-up.
Primary Outcome
The primary outcome measure will be percent days of abstinence (PDA) by week, presented are the raw means at each time point.
Interventions
- BEHAVIORAL Standard Treatment (ST)
- BEHAVIORAL Standard treatment (ST) PLUS web-based CBT4CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2019-08-06 |
| Est. Completion | 2023-08-16 |
| Phase | NA |
What the finished NCT03474588 record still lists
NCT03474588 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Treatment (ST) is the first listed.
NCT03474588 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03474588 about?
NCT03474588 is a clinical study titled "CBT4CBT With Spanish Alcohol Users". Specific aims are as follows: * To adapt our existing CBT4CBT program for use with Spanish-speaking alcohol users in a web-based platform * To conduct an 8-week randomized trial evaluating the feasibility and efficacy of adding CBT4CBT-Spanish to treatment as usual in a community based treatment pr...
What is the current status of trial NCT03474588?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2019-08-06. Estimated completion is 2023-08-16.
What interventions are being tested in trial NCT03474588?
The interventions under investigation include: Standard Treatment (ST) (BEHAVIORAL), Standard treatment (ST) PLUS web-based CBT4CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT03474588?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03474588's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI